Table 1

ADAMTS-18 385-AA fragment given 2 hours before or after obstruction of right middle cerebral artery and examined 8 days after removal of obstruction

No.% InfarctPostural reflex*Rotor rodTransverse beam
385AA 13 23.9 ± 4.0 1.02 ± 0.17 4.62 ± 0.58 5.97 ± 0.48 
66AA+ 43.8 ± 7.3 2.87 ± 0.13 3.23 ± 0.45 3.87 ± 0.90 
Saline 14 43.0 ± 4.8 2.31 ± 0.25 3.19 ± 0.34 4.52 ± 0.46 
P§  < .001 < .002 < .04 < .01 
No.% InfarctPostural reflex*Rotor rodTransverse beam
385AA 13 23.9 ± 4.0 1.02 ± 0.17 4.62 ± 0.58 5.97 ± 0.48 
66AA+ 43.8 ± 7.3 2.87 ± 0.13 3.23 ± 0.45 3.87 ± 0.90 
Saline 14 43.0 ± 4.8 2.31 ± 0.25 3.19 ± 0.34 4.52 ± 0.46 
P§  < .001 < .002 < .04 < .01 
*

Higher number reflects greater neurologic damage.

Lower number reflects greater neurologic damage.

§

Student t test comparison of intravenous injections of saline vehicle versus 35 μg ADAMTS-18 385-AA fragment versus functionally inactive ADAMTS-18 66-AA fragment (control). Since differences were not noted between pre– and post–ADAMTS-18 385-AA fragment infusion, both groups were averaged.

Close Modal

or Create an Account

Close Modal
Close Modal